#

Eli Lilly

: 87
Eli Lilly has once again expanded its portfolio of potential new drugs this year / Photo: Tada Images/Shutterstock.com
News·
Eli Lilly has found a new acquisition target. The company has already spent $20 billion this year
Eli Lilly Raises Forecast Thanks to the Success of Its Weight-Loss Drugs / Photo: Tada Image / Shutterstock.com
News·
Lilly raised its revenue forecast. This eased fears that the weight-loss boom is on the decline
Elon Musks SpaceX will release its first quarterly report this week following its IPO / Photo: X/SpaceX
News·
SpaceX's Earnings Report, the Job Market, and Big Pharma: What Investors Can Expect This Week
Profits at British pharmaceutical giant AstraZeneca exceeded analysts expectations last quarter. Photo: Konektus Photo/Shutterstock
News·
Oncology drugs helped boost AstraZeneca's profits by 21%. Will the company expand its portfolio?
Novo Nordisk Accuses Eli Lilly of Unfair Advertising / Photo: oleschwander / Shutterstock
News·
Novo has filed a lawsuit against its competitor, Eli Lilly, over advertisements for weight-loss drugs
The transaction gives Eli Lilly access to AtaiBeckley’s experimental drug being studied in phase III clinical trials for treatment-resistant depression / Photo: Shutterstock.com / Tada Images
News·
+1
·
Eli Lilly officially to acquire psychedelics drugmaker AtaiBeckley for $3.8 bln
BlackRock warned clients against investing in Chinese indices / Photo: John Hanson Pye/Shutterstock.com
News·
BlackRock advised investors to focus on specific AI stocks in China rather than the entire region
Eli Lillys new obesity drug led to weight loss by more than a quarter / Photo: Jonathan Weiss / Shutterstock.com
News·
'Eli Lilly pulls ahead': investors praise new obesity drug
Growing revenues from weight management products allow Eli Lilly to actively increase investments and develop new directions. Photo: Jonathan Weiss / Shutterstock.com
Review·
Defeating dementia: where Eli Lilly is investing $4 billion
Eli Lilly will buy three vaccine developers. Photo: ChrisStock82/Shutterstock
News·
Eli Lilly will invest nearly $4 billion to buy three vaccine developers. Why would she do that?
Photo: X/NYSE
News·
Morning in New York: the situation is favorable for buying
Eli Lilly grew profits by 168% and raised its full-year forecast / Photo: Tada Images / Shutterstock
News·
Eli Lilly grew earnings 168% and raised its full-year guidance. What's up with the stock?
Load more